Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Verastem
Verastem
Verastem Inc.'s Upcoming Catalysts
Motley Fool
Sun, 06/22/14 - 09:20 am
Verastem
Three Biotechs That Could Double
Yahoo/Street Authority
Thu, 06/5/14 - 09:29 am
Verastem
Versartis
Threshold Pharmaceuticals
Verastem publishes data on targeting mesothelioma cancer stem cells
The Fly on the Wall
Tue, 05/27/14 - 09:26 am
Verastem
mesothelioma
stem cells
Verastem: Cancer May Have Met Its Match
Seeking Alpha
Mon, 04/21/14 - 10:00 am
Verastem
cancer
stem cells
Verastem acquires the license to VS-4718 originally held by Poniard
Yahoo/Fly on the Wall
Tue, 02/25/14 - 07:38 am
Verastem
VS-4718
Poniard
stem cells
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Fierce Biotech
Fri, 01/17/14 - 05:54 pm
JPMHC 2014
Algeta
Macrogenics
Xencor
Acetylon
Enanta Pharmaceuticals
Clinigen
Iroko Pharmaceuticals
Protalix BioTherapeutics
Ambrx
Roche
Sialix
Verastem
pRED
Cubist Pharmaceuticals
Celgene
Otonomy
Lumena Pharmaceuticals
Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool
Tue, 12/10/13 - 11:36 am
Verastem
Cell Therapeutics
Novartis
Geron
imetelstat
Jakavi
myelofibrosis
tosedostat
AML
VS-5584
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer
Yahoo
Thu, 09/26/13 - 09:48 am
Defactinib
Verastem
non-small cell lung cancer
Verastem Reports on Ongoing Trials at Cancer Advance at Harvard Medical School
Yahoo
Fri, 09/20/13 - 10:18 am
clinical trials
Harvard
Verastem
Defactinib
mesothelioma
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space
Seeking Alpha
Tue, 09/17/13 - 09:54 am
stem cells
cancer
Verastem
VS-4718
Defactinib
VS-5584
Verastem Initiates Phase 1 Clinical Trial of VS-4718 in Patients with Advanced Cancer
Yahoo
Wed, 06/26/13 - 10:43 am
VS-4718
Verastem
clinical trials
stem cells
advanced cancer
Verastem Reports Year-End 2012 Financial Results
Yahoo
Wed, 03/27/13 - 12:29 pm
Verastem
earnings
ImmunoCellular CEO Steps Down But Leaves Company Well Positioned
Seeking Alpha
Tue, 08/21/12 - 11:32 am
ImmunoCellular Therapeutics
Dendreon
Jazz Pharmaceuticals
Merck
Verastem
Roche
Oncothyreon
AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha
Fri, 08/17/12 - 11:34 am
M&A
AstraZeneca
Bristol-Myers Squibb
JNJ
Verastem
Eli Lilly
Pfizer
Eli Lilly, Verastem and the Defenders of Shareholder Value
TheStreet.com
Mon, 07/16/12 - 12:16 pm
Eli Lilly
Verastem
Celgene
QLT
Amylin
Verastem's Chances Are Slimmer Than Investment Banks Would Have You Think
Seeking Alpha
Tue, 03/13/12 - 11:49 am
Verastem
IPOs
10 Biotechs Targeting Cancer Stem Cell Destruction
Minyanville
Mon, 03/5/12 - 11:51 am
stem cells
Stemica
OncoMed
KaloBios
Stemline
Formula Pharmaceuticals
Eclipse Pharmaceuticals
Verastem
ImmunoCellular
Geron
EntreMed
Verastem IPO Looks Like Risky Bet
TheStreet.com
Thu, 01/26/12 - 11:23 am
IPO
Verastem
GSK
Pfizer
IPO Preview: Verastem
Seeking Alpha
Wed, 01/25/12 - 12:36 pm
IPOs
Verastem
Astellas
GSK
Pfizer
Sanofi
With IPO pending, Verastem raises $20M
Bizjournals.com
Fri, 11/11/11 - 12:03 pm
Verastem
IPO
Pages
« first
‹ previous
1
2